{"gene":"TOPORS","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":2004,"finding":"TOPORS functions as a RING domain-dependent E3 ubiquitin ligase in vitro, utilizing E2 enzymes UbcH5a, UbcH5c, and UbcH6 (but not UbcH7, CDC34, or UbcH2b), and ubiquitinates p53 both in vitro and in cells; a conserved tryptophan in the RING domain is required for ubiquitination activity; overexpression leads to proteasome-dependent decrease in p53 protein levels.","method":"In vitro ubiquitination assay, RING domain mutagenesis, cellular overexpression with proteasome inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis, multiple E2 specificity tested, replicated in cellular context","pmids":["15247280"],"is_preprint":false},{"year":2005,"finding":"TOPORS acts as a SUMO-1 E3 ligase for p53, enhancing SUMO-1 conjugation to p53 both in vivo and in a reconstituted in vitro system; this SUMO-1 E3 ligase activity does not require the RING finger motif; in HeLa cells, Topors-induced p53 sumoylation was accompanied by increased endogenous p53 protein levels.","method":"Reconstituted in vitro SUMO-1 conjugation assay, cellular co-transfection, RING finger deletion mutants","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution plus cellular validation, RING-independence established by mutagenesis","pmids":["16122737"],"is_preprint":false},{"year":2005,"finding":"DJ-1 binds TOPORS/p53BP3 in vitro and in vivo; TOPORS mediates sumoylation of both p53 and DJ-1 in cells; TOPORS-mediated sumoylation of p53 abrogates p53 transcriptional activity in a dose-dependent manner; DJ-1 restores repressed p53 transcriptional activity by releasing the sumoylated form of p53.","method":"Co-IP, in vitro binding assay, co-localization, transcriptional reporter assay, cellular sumoylation assay","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal binding confirmed in vitro and in vivo, functional consequence on p53 transcription measured; single lab","pmids":["15703819"],"is_preprint":false},{"year":2002,"finding":"Topors localizes to promyelocytic leukemia (PML) nuclear bodies in a PML-dependent manner; the basic C-terminal region (not the RING domain) is required for punctate nuclear localization; topors dynamically relocalizes from nuclear bodies to the nucleoplasm upon treatment with transcription inhibitor DRB or the topoisomerase I-targeting drug camptothecin.","method":"GFP fusion live imaging, fractionation, isogenic PML+/+ vs PML-/- MEFs, domain deletion analysis, drug treatment","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization with functional domain mapping, isogenic cell comparison, multiple treatments","pmids":["12083797"],"is_preprint":false},{"year":2003,"finding":"TOPORS is itself a SUMO-1 modification target; it interacts with SUMO-1 and the SUMO-1 conjugating enzyme UBC9 in yeast two-hybrid; multiple SUMO-1 modified forms of Topors are detected after co-transfection; lysine 560 within the central domain (residues 437–574) is a SUMO-1 acceptor site; sumoylation-deficient mutants show that sumoylation is not required for localization to nuclear speckles.","method":"Yeast two-hybrid, co-transfection and immunoblot, YFP-SUMO-1 colocalization, site-directed mutagenesis","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — site-directed mutagenesis identifying K560, multiple orthogonal methods in single lab","pmids":["14516784"],"is_preprint":false},{"year":2004,"finding":"Drosophila Topors (dTopors) functions as an E3 ubiquitin-protein isopeptide ligase in vitro and mediates polyubiquitination and degradation of the Hairy transcriptional repressor; dTopors binds specifically to the basic region of Hairy but does not affect Hairy's DNA binding; reducing dtopors gene dose genetically antagonizes Hairy-mediated transcriptional repression.","method":"In vitro ubiquitination assay with recombinant dTopors, genetic dose reduction (epistasis), co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution plus genetic epistasis in Drosophila ortholog, multiple orthogonal methods","pmids":["14871887"],"is_preprint":false},{"year":2005,"finding":"Mouse topors associates with and stabilizes p53, enhances p53-dependent transcriptional activities (p21Waf1, MDM2, Bax promoters), elevates endogenous p21Waf1 mRNA, and overexpression suppresses cell growth by cell cycle arrest and/or apoptosis; topors expression is induced by genotoxic agents cisplatin and camptothecin.","method":"Co-IP, transcriptional reporter assays, RT-PCR, cell growth/apoptosis assays, overexpression","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional readouts (transcription, growth, apoptosis) in single lab; co-IP validates physical association","pmids":["15735665"],"is_preprint":false},{"year":2007,"finding":"TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins; proteomic screen identified candidate substrates involved in chromatin modification/transcriptional regulation; mammalian Sin3A was confirmed as a sumoylation substrate for TOPORS by transfection studies.","method":"Proteomic screen, transfection-based sumoylation assay","journal":"Journal of proteome research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — substrate confirmed by cellular assay, no in vitro reconstitution for Sin3A; single lab","pmids":["17803295"],"is_preprint":false},{"year":2007,"finding":"TOPORS enhances formation of high-molecular-weight SUMO-1 conjugates (poly-SUMO-1 chains) on DNA topoisomerase I (TOP1) in a reconstituted in vitro system and in human osteosarcoma cells; TOP1 point mutants suggest chains form on a limited number of SUMO-1 acceptor sites.","method":"Reconstituted in vitro SUMO-1 conjugation assay, cellular overexpression, TOP1 point mutant analysis","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis of substrate, replicated in cells; single lab","pmids":["17976381"],"is_preprint":false},{"year":2007,"finding":"TOPORS mutations (insertion and deletion causing haploinsufficiency) cause autosomal dominant retinitis pigmentosa (RP31); TOPORS localizes in the nucleus in speckled loci associated with PML bodies; lack of mutant protein in patients suggests haploinsufficiency as disease mechanism.","method":"Positional cloning, mutation identification by sequencing, immunolocalization","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — positional cloning with functional localization; disease mechanism established by genetics and protein expression analysis","pmids":["17924349"],"is_preprint":false},{"year":2007,"finding":"TOPORS ubiquitinates the prostate tumor suppressor NKX3.1 in vitro and in vivo; overexpression of TOPORS leads to NKX3.1 proteasomal degradation in prostate cancer cells; siRNA knockdown of TOPORS increases steady-state NKX3.1 levels and prolongs its half-life.","method":"In vitro ubiquitination assay, cellular overexpression, siRNA knockdown, cycloheximide chase","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution plus loss-of-function and gain-of-function cellular studies with half-life measurement","pmids":["18077445"],"is_preprint":false},{"year":2008,"finding":"Phosphorylation of serine 98 (adjacent to the RING domain) regulates TOPORS ubiquitin ligase activity: S98D (phosphomimetic) increases ubiquitin ligase activity and binding to E2 enzyme UbcH5a both in vitro and in cells; this phosphorylation does not affect SUMO ligase activity or punctate nuclear localization. Multiple phosphorylated regions were identified by mass spectrometry.","method":"Mass spectrometry, site-directed mutagenesis (S98A, S98D), in vitro ubiquitination assay, co-IP with E2","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with in vitro assay and cellular validation; clear separation of ubiquitin vs SUMO activities","pmids":["19053840"],"is_preprint":false},{"year":2009,"finding":"Plk1 phosphorylates Topors on Ser718 in vivo; expression of Plk1-unphosphorylatable Topors (S718A) leads to dramatic p53 accumulation through inhibition of p53 degradation; Plk1-mediated phosphorylation of Topors inhibits Topors-mediated sumoylation of p53 while enhancing p53 ubiquitination, leading to p53 degradation.","method":"In vivo phosphorylation assay, site-directed mutagenesis (S718A), p53 stability assay, ubiquitination and sumoylation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — phosphorylation site identified in vivo with phospho-deficient mutant, mechanistic dissection of opposing E3 activities","pmids":["19473992"],"is_preprint":false},{"year":2009,"finding":"Plk1-associated phosphorylation of Topors at S718 is essential for nocodazole-induced degradation of Topors; Topors depletion delays mitotic entry and affects mitotic progression, implicating Topors in normal mitotic progression.","method":"Spindle checkpoint activation (nocodazole), siRNA knockdown, phosphorylation analysis","journal":"Molecular biology reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — loss-of-function with defined mitotic phenotype, single lab, single method confirmation","pmids":["19821153"],"is_preprint":false},{"year":2010,"finding":"TOPORS localizes to the basal bodies of the connecting cilium in photoreceptors and to centrosomes in cultured cells; morpholino-mediated silencing of topors in zebrafish results in defective retinal development and failure to form outer segments, phenotypes rescued by mRNA encoding human TOPORS.","method":"Immunolocalization in retinal sections, morpholino knockdown in zebrafish, mRNA rescue experiment","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization tied to functional consequence, loss-of-function with rescue in zebrafish model","pmids":["21159800"],"is_preprint":false},{"year":2010,"finding":"Topors-deficient mouse embryonic fibroblasts exhibit increased malignant transformation associated with aneuploidy and defective chromosomal segregation; Topors-deficient cells show mislocalization of HP1alpha and increased transcription from pericentric major satellite DNA, indicating altered pericentric heterochromatin; these cells are resistant to anti-proliferative effects of the HDAC inhibitor trichostatin A.","method":"Topors knockout mouse, MEF transformation assay, FISH for aneuploidy, HP1alpha immunolocalization, RT-PCR of satellite DNA, HDAC inhibitor treatment","journal":"BMC molecular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse model with multiple orthogonal mechanistic readouts (chromosomal segregation, heterochromatin, HDAC sensitivity)","pmids":["20429939"],"is_preprint":false},{"year":2012,"finding":"TOPORS interacts with H2AX and functions as an E3 ubiquitin ligase for H2AX in vitro; TOPORS overexpression decreases H2AX protein stability; TOPORS dissociates from H2AX under oxidative stress (hydrogen peroxide, ionizing radiation) but not under replication-stress-inducing damage.","method":"Co-IP from mammalian cell extracts, in vitro ubiquitination assay, overexpression stability assay, stress-dependent dissociation analysis","journal":"Journal of biochemical and molecular toxicology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vitro ubiquitination with cellular co-IP and functional consequence; single lab, limited methods","pmids":["22972498"],"is_preprint":false},{"year":2012,"finding":"Syndecan-1 cytoplasmic domain (S1CD) interacts with Topors via a specific 18-amino acid sequence of Topors identified by deletion mutagenesis; Topors and Sdc-1 co-localize near the cell periphery; siRNA knockdown of Topors demonstrates Topors is required for the inhibitory effect of Sdc-1 on cell growth and PDGF-B induction in arterial smooth muscle cells.","method":"Yeast two-hybrid, ligand blotting, co-precipitation, deletion mutagenesis, immunohistochemistry, siRNA knockdown","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — interaction domain mapped by mutagenesis, functional consequence confirmed by siRNA; single lab","pmids":["22912899"],"is_preprint":false},{"year":2016,"finding":"TOPORS interacts with the 26S protease regulatory subunit 4 (P26s4/PSMC1), an ATPase component of the proteasome; interaction validated by yeast two-hybrid, co-immunoprecipitation from mammalian cells, and immunofluorescent co-localization; TOPORS and P26s4 co-localize at the centrosome in cultured hTERT-RPE1 and 661W cells.","method":"Yeast two-hybrid screen of human retinal cDNA library, co-IP from mammalian cells, immunofluorescence co-localization","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — interaction validated by reciprocal co-IP and two cell line co-localization; single lab","pmids":["26872363"],"is_preprint":false},{"year":2020,"finding":"TOPORS knockdown in mouse hepatocytes increases chromatin interactions between A and B compartments, reduces compartmentalization strength, weakens TAD boundaries at A/B borders, decreases chromatin-lamina interactions (LAD coverage from 53.31% to 46.52%), and alters chromatin accessibility predominantly at intergenic regions including enhancers; these changes are associated with PML nuclear bodies and PML-associated domains.","method":"Hi-C, ATAC-seq, ChIP-seq, RNA-seq after Topors knockdown in mouse hepatocytes","journal":"Biochimica et biophysica acta. Gene regulatory mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genome-wide orthogonal methods; single lab, loss-of-function with defined chromatin structural phenotype","pmids":["32113985"],"is_preprint":false},{"year":2022,"finding":"TOPORS mediates SUMOylation of RAD51 at lysine residues K57 and K70 in response to DNA damage; this SUMOylation is facilitated by ATM-induced phosphorylation of TOPORS at threonine 515; SUMOylation-deficient RAD51 mutants exhibit reduced chromatin loading and HR repair efficiency, and reduced association with BRCA2.","method":"In vivo SUMOylation assay, site-directed mutagenesis of RAD51 (K57R, K70R), phosphorylation analysis of TOPORS T515, HR repair assay, co-IP with BRCA2, chromatin fractionation","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — specific SUMOylation sites mapped by mutagenesis, upstream kinase identified, functional consequence in HR repair with mechanistic explanation (BRCA2 interaction)","pmids":["35061896"],"is_preprint":false},{"year":2022,"finding":"TOPORS binds the SMAR1 promoter (confirmed by ChIP) and its occupancy increases upon LPS treatment; TOPORS is induced via the TLR4-TRIF pathway by LPS; TOPORS-mediated transcriptional upregulation of SMAR1 subsequently represses STAT3 and shifts tumor-associated macrophage polarization toward M1 phenotype.","method":"ChIP analysis, siRNA knockdown, LPS treatment, macrophage polarization assay","journal":"Molecular oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms direct promoter binding; pathway placement by genetic knockdown; single lab","pmids":["34689394"],"is_preprint":false},{"year":2024,"finding":"TOPORS functions as a SUMO-targeted ubiquitin ligase (STUbL), combining RING domain-mediated ubiquitin ligase activity with poly-SUMO binding via SUMO-interacting motifs; TOPORS is SUMO1-selective and complements RNF4 (which is SUMO2/3-selective) in generating complex ubiquitin landscapes on SUMOylated targets including DNA-protein crosslinks (DPCs) and PML, stimulating p97/VCP recruitment and proteasomal degradation; combined loss of TOPORS and RNF4 is synthetic lethal in unstressed cells due to defective clearance of SUMOylated proteins from chromatin, leading to cell cycle arrest and apoptosis.","method":"Genome-scale CRISPR screens, in vitro ubiquitination assay, SUMO-interaction motif mapping, p97 recruitment assay, synthetic lethality double-knockout, cell cycle analysis","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — genome-scale screens combined with in vitro reconstitution, domain mapping, synthetic lethality, and mechanistic pathway placement; single lab with multiple orthogonal methods","pmids":["38649616"],"is_preprint":false},{"year":2024,"finding":"TOPORS is recruited to SUMOylated DNMT1-DNA protein crosslinks (DPCs) and promotes their ubiquitin-dependent degradation; TOPORS knockout stabilizes SUMOylated DNMT1 following treatment with DNA hypomethylating agents (5-aza-dC); the TOPORS RING finger domain is responsible for this ubiquitination-mediated DPC resolution.","method":"CRISPR/Cas9 screens, proximity proteomics of DNMT1-DPC, TOPORS knockout/knockdown, SUMOylated DNMT1 immunoblot, RING domain mutant analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-scale screen plus proximity proteomics plus genetic knockout with domain mapping; two independent groups confirmed mechanistically overlapping findings","pmids":["38760575"],"is_preprint":false},{"year":2024,"finding":"TOPORS knockout predisposes leukemic blasts to impaired DNA damage response (DDR) and accumulation of SUMOylated DNMT1 when treated with HMAs; depletion of TOPORS synergizes with HMAs to reduce leukemic burden in xenograft models; combination does not impair healthy hematopoiesis.","method":"Genome-wide CRISPR-Cas9 screen, xenograft mouse model, SUMOylated DNMT1 immunoblot, DDR assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide screen with in vivo xenograft validation and mechanistic DDR readout; independent replication of TOPORS-DPC mechanism across multiple labs","pmids":["39198401"],"is_preprint":false},{"year":2024,"finding":"TOPORS knockout stabilizes DNMT1 by preventing its ubiquitination following HMA treatment, resulting in accumulation of unresolved SUMOylated DNMT1; the TOPORS RING finger domain mediates ubiquitination of SUMOylated DNMT1, promoting resolution of DNA-DNMT1 crosslinks.","method":"CRISPR-Cas9 knockout, DNMT1 stability assay, ubiquitination assay, RING finger domain analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain-level mechanism established, independent replication of DPC/DNMT1 substrate across three concurrent publications","pmids":["39198387"],"is_preprint":false},{"year":2025,"finding":"TOPORS is a SUMO1-selective STUbL that is recruited to PML only when sufficient SUMO1 conjugation occurs (not SUMO2/3 alone); arsenic-resistant PML mutant A216T fails to recruit TOPORS because arsenic does not trigger its SUMOylation; arsenic-resistant PML mutant L217F acquires SUMO2/3 but not SUMO1 conjugation sufficient to recruit TOPORS; thus TOPORS and RNF4 act in parallel on distinct SUMO chains to generate the polyubiquitin signal for p97 binding and PML degradation.","method":"PML-/- cell reconstitution with YFP-PML fusions (WT, A216T, L217F), arsenic treatment, SUMO-1 and SUMO2/3 conjugation assays, TOPORS and RNF4 recruitment assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — isogenic cell reconstitution with patient-derived mutants, SUMO isoform selectivity mechanistically dissected, multiple orthogonal methods","pmids":["40239066"],"is_preprint":false},{"year":2025,"finding":"TOPORS is identified as a substrate of the deubiquitinase USP7; USP7 inhibition leads to reduced TOPORS protein levels; TOPORS interacts with the BRCA1-A DNA damage repair complex, suggesting a USP7-TOPORS-BRCA1-A axis.","method":"Quantitative proteomics after USP7 inhibition, protein interaction network analysis (BRCA1-A complex co-identification)","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, proteomics-based substrate inference; BRCA1-A interaction not directly validated by co-IP in this abstract","pmids":["bio_10.1101_2025.01.28.635372"],"is_preprint":true},{"year":2025,"finding":"TOPORS regulates SUMO1 modification of TOP1 in macrophages exposed to ovalbumin-induced oxidative stress; knockdown of TOPORS reduces SUMO1-TOP1 levels and increases unrepaired DNA damage (γH2AX), indicating TOPORS-mediated TOP1 sumoylation contributes to DNA damage repair in this context.","method":"Immunoprecipitation of SUMO1-TOP1, siRNA knockdown of TOPORS, γH2AX immunoblot in OVA-stimulated macrophages","journal":"Toxicology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — co-IP validated SUMOylation with functional readout (γH2AX); single lab, single context","pmids":["40532862"],"is_preprint":false},{"year":2001,"finding":"LUN/TOPORS (RING finger protein) localizes to the nucleus and exhibits Zn2+-dependent DNA binding activity; the region from amino acids 51–374 is responsible for DNA binding; a palindromic binding consensus sequence (5'-TCCCAGCACTTTGGGA-3') was identified for LUN/TOPORS binding.","method":"Nuclear localization by immunofluorescence, DNA binding assay (Zn2+-dependence), deletion mapping, binding consensus identification","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct DNA binding demonstrated with domain mapping and consensus sequence identification; single lab","pmids":["11278651"],"is_preprint":false}],"current_model":"TOPORS is a dual E3 ligase—bearing both ubiquitin (RING domain-dependent, with E2 selectivity for UbcH5a/c and UbcH6) and SUMO-1 (RING-independent) activities—that acts as a SUMO1-selective SUMO-targeted ubiquitin ligase (STUbL) complementing RNF4 to generate complex ubiquitin landscapes on poly-SUMOylated substrates including p53, NKX3.1, H2AX, DNA topoisomerase I, RAD51, Sin3A, and DNMT1-DNA protein crosslinks, thereby regulating proteasomal degradation via p97/VCP recruitment, homologous recombination repair, pericentric heterochromatin integrity, and 3D chromatin architecture; its activities are regulated by phosphorylation (Plk1 on S718 and ATM on T515), it localizes to PML nuclear bodies (C-terminal basic region required) and to centrosomes/basal bodies of photoreceptor cilia, and haploinsufficiency or specific C-terminal truncating mutations in the 807–867 region cause autosomal dominant retinitis pigmentosa."},"narrative":{"mechanistic_narrative":"TOPORS is a dual-function nuclear E3 ligase that conjugates both ubiquitin and SUMO-1 to substrates, thereby coupling SUMO signaling to proteasomal turnover and chromatin regulation [PMID:15247280, PMID:16122737]. Its ubiquitin ligase activity depends on an intact RING domain and a conserved tryptophan, and operates through the E2 enzymes UbcH5a, UbcH5c, and UbcH6 [PMID:15247280], whereas its SUMO-1 ligase activity is RING-independent [PMID:16122737]. This bifunctionality is integrated at the level of individual targets: on p53, TOPORS can both stabilize the protein through SUMOylation and drive its proteasomal degradation through ubiquitination, with the balance set by phosphorylation [PMID:15247280, PMID:16122737, PMID:19473992]. The mature mechanistic model casts TOPORS as a SUMO1-selective SUMO-targeted ubiquitin ligase (STUbL) that recognizes poly-SUMO1 chains via SUMO-interacting motifs and complements the SUMO2/3-selective RNF4, the two acting in parallel on distinct SUMO chains to build the polyubiquitin signal that recruits p97/VCP and triggers degradation; combined loss of TOPORS and RNF4 is synthetic lethal due to failed clearance of SUMOylated chromatin proteins [PMID:38649616, PMID:40239066]. Through this activity TOPORS ubiquitinates SUMOylated DNA-protein crosslinks, most notably DNMT1-DPCs formed after hypomethylating-agent treatment, promoting their RING-dependent resolution—a dependency exploited therapeutically in leukemia [PMID:38760575, PMID:39198401, PMID:39198387]. TOPORS also SUMOylates RAD51 at K57 and K70 downstream of ATM-mediated phosphorylation of TOPORS T515, promoting RAD51 chromatin loading, BRCA2 association, and homologous recombination repair [PMID:35061896]. Additional substrates include NKX3.1, which it targets for proteasomal degradation [PMID:18077445], topoisomerase I and Sin3A, which it poly-SUMOylates [PMID:17803295, PMID:17976381]. TOPORS localizes to PML nuclear bodies via its basic C-terminal region in a PML-dependent manner [PMID:12083797] and to centrosomes and photoreceptor connecting-cilium basal bodies [PMID:21159800, PMID:26872363], and its activities are temporally controlled by Plk1 phosphorylation at S718 [PMID:19473992]. Loss-of-function studies link TOPORS to pericentric heterochromatin integrity, chromosome segregation, and 3D chromatin compartmentalization [PMID:20429939, PMID:32113985]. Haploinsufficiency and truncating TOPORS mutations cause autosomal dominant retinitis pigmentosa (RP31) [PMID:17924349].","teleology":[{"year":2001,"claim":"Before any enzymatic role was known, the question was whether TOPORS had intrinsic nucleic-acid activity; demonstrating Zn2+-dependent sequence-specific DNA binding established it as a nuclear factor capable of chromatin association.","evidence":"Immunofluorescence, Zn2+-dependent DNA-binding assay, deletion mapping and consensus identification for LUN/TOPORS","pmids":["11278651"],"confidence":"Medium","gaps":["No demonstrated transcriptional output from this DNA-binding consensus in vivo","Relationship between DNA binding and later-defined ligase activities unresolved"]},{"year":2002,"claim":"The subnuclear address of TOPORS was unknown; localization to PML nuclear bodies dependent on PML and on a basic C-terminal region, with drug-induced relocalization, placed TOPORS at the SUMO/PML hub and mapped the targeting determinant.","evidence":"GFP live imaging, PML+/+ vs PML-/- MEFs, domain deletion, DRB and camptothecin treatment","pmids":["12083797"],"confidence":"High","gaps":["Functional consequence of PML-body residence not addressed at this stage","Mechanism of camptothecin-induced relocalization unexplained"]},{"year":2003,"claim":"Whether TOPORS itself is SUMO-regulated was untested; identifying K560 as a SUMO-1 acceptor and UBC9/SUMO-1 interactions showed TOPORS is a SUMO substrate, foreshadowing its embedding in the SUMO machinery.","evidence":"Yeast two-hybrid, co-transfection immunoblot, YFP-SUMO-1 colocalization, K560 mutagenesis","pmids":["14516784"],"confidence":"High","gaps":["Functional role of TOPORS auto-SUMOylation undefined (not required for localization)","Did not establish TOPORS as a SUMO ligase itself"]},{"year":2004,"claim":"The catalytic identity of TOPORS was open; reconstitution showed RING-dependent ubiquitin ligase activity with defined E2 selectivity and p53 as a degradation substrate, defining its first enzymatic function.","evidence":"In vitro ubiquitination with E2 panel, RING tryptophan mutagenesis, cellular overexpression with proteasome inhibitor; Drosophila ortholog ubiquitinating Hairy with genetic epistasis","pmids":["15247280","14871887"],"confidence":"High","gaps":["In vivo physiological substrate repertoire not yet defined","Did not reconcile p53 degradation with later p53-stabilizing observations"]},{"year":2005,"claim":"It was unclear whether TOPORS had a second catalytic activity; demonstrating RING-independent SUMO-1 ligase activity toward p53 (and DJ-1), with opposing effects on p53 stability and transcription, established TOPORS as a dual ubiquitin/SUMO ligase.","evidence":"Reconstituted in vitro SUMO-1 assays, RING-deletion mutants, co-IP, transcriptional reporters, mouse Topors p53 stabilization studies","pmids":["16122737","15703819","15735665"],"confidence":"High","gaps":["How a single enzyme reconciles ubiquitination-driven degradation and SUMOylation-driven stabilization of p53 not yet resolved","Physiological switch between the two activities unknown"]},{"year":2007,"claim":"The substrate breadth and chromatin role were unclear; identifying Sin3A and demonstrating poly-SUMO-1 chain formation on TOP1 broadened the SUMO-ligase function toward chromatin and topoisomerase regulation.","evidence":"Proteomic substrate screen, transfection sumoylation of Sin3A, reconstituted poly-SUMO-1 chain assay on TOP1 with mutant mapping","pmids":["17803295","17976381"],"confidence":"High","gaps":["No in vitro reconstitution for Sin3A SUMOylation","Downstream fate of poly-SUMO-1 chains not yet linked to ubiquitin/degradation"]},{"year":2007,"claim":"Whether TOPORS dysfunction causes human disease was unknown; positional cloning tied haploinsufficiency-causing mutations to autosomal dominant retinitis pigmentosa (RP31), establishing a Mendelian phenotype.","evidence":"Positional cloning, mutation sequencing, immunolocalization to PML-associated speckles; NKX3.1 ubiquitination/degradation in parallel cancer study","pmids":["17924349","18077445"],"confidence":"Medium","gaps":["Molecular basis of retinal-specific vulnerability not explained by haploinsufficiency alone","Connection between p53/NKX3.1 ligase activity and retinal degeneration unclear"]},{"year":2008,"claim":"How the two ligase activities are independently regulated was unknown; phosphorylation at S98 selectively stimulating ubiquitin ligase activity and E2 binding without affecting SUMO activity showed the activities are separable post-translational switches.","evidence":"Mass spectrometry, S98A/S98D mutants, in vitro ubiquitination, co-IP with UbcH5a","pmids":["19053840"],"confidence":"High","gaps":["Kinase responsible for S98 phosphorylation not identified","Physiological trigger for this modification unknown"]},{"year":2009,"claim":"The cell-cycle control of TOPORS activity was undefined; Plk1 phosphorylation at S718 was shown to flip TOPORS from p53-SUMOylation toward p53-ubiquitination/degradation and to govern TOPORS turnover and mitotic progression.","evidence":"In vivo phosphorylation, S718A mutant, p53 stability/ubiquitination/sumoylation assays; nocodazole and siRNA mitotic phenotyping","pmids":["19473992","19821153"],"confidence":"High","gaps":["Mechanism by which one phosphorylation toggles between two enzymatic outputs not structurally defined","Mitotic substrates other than p53 not identified"]},{"year":2010,"claim":"The cellular and organismal consequences of TOPORS loss were unclear; knockout MEFs revealed roles in chromosome segregation and pericentric heterochromatin, while zebrafish silencing tied TOPORS to ciliary/photoreceptor outer-segment formation with human-mRNA rescue.","evidence":"Topors knockout mouse MEFs, FISH aneuploidy, HP1alpha localization, satellite RT-PCR, HDAC inhibitor sensitivity; zebrafish morpholino with rescue and basal-body localization","pmids":["20429939","21159800"],"confidence":"High","gaps":["Molecular substrate underlying heterochromatin and segregation defects not identified","Mechanistic link between nuclear ligase activity and ciliary basal-body function unresolved"]},{"year":2012,"claim":"Additional substrates and cytoplasmic partners were sought; TOPORS was shown to ubiquitinate H2AX (with stress-dependent dissociation) and to bind the syndecan-1 cytoplasmic domain required for growth inhibition, extending its reach to DNA-damage histones and membrane signaling.","evidence":"Co-IP, in vitro H2AX ubiquitination, stability assays, oxidative-stress dissociation; yeast two-hybrid, deletion mapping and siRNA for syndecan-1","pmids":["22972498","22912899"],"confidence":"Medium","gaps":["H2AX work limited to single lab without reciprocal stress validation","Syndecan-1/TOPORS axis mechanism downstream of binding not defined"]},{"year":2016,"claim":"How TOPORS connects to the degradation machinery and to its disease-relevant localization was unclear; interaction with the proteasomal ATPase PSMC1 and co-localization at the centrosome linked TOPORS physically to the proteasome at a structure relevant to RP.","evidence":"Retinal cDNA yeast two-hybrid, reciprocal co-IP, immunofluorescence co-localization in RPE1 and 661W cells","pmids":["26872363"],"confidence":"Medium","gaps":["Functional consequence of TOPORS-PSMC1 interaction at the centrosome untested","Single lab; not connected to specific substrate degradation"]},{"year":2020,"claim":"Whether TOPORS shapes genome architecture was unknown; knockdown altering A/B compartmentalization, TAD boundaries, lamina interactions and accessibility tied TOPORS to 3D chromatin organization linked to PML domains.","evidence":"Hi-C, ATAC-seq, ChIP-seq, RNA-seq after Topors knockdown in mouse hepatocytes","pmids":["32113985"],"confidence":"Medium","gaps":["Direct molecular mediator of architectural changes not identified","Causality versus secondary effect of PML-body disruption unresolved"]},{"year":2022,"claim":"Whether TOPORS participates in HR repair was open; mapping ATM-dependent T515 phosphorylation and TOPORS-mediated RAD51 SUMOylation at K57/K70 promoting chromatin loading and BRCA2 association placed TOPORS in the damage-induced HR pathway, alongside an immune transcriptional role at the SMAR1 promoter.","evidence":"In vivo SUMOylation, RAD51 and TOPORS site mutants, HR assay, BRCA2 co-IP, chromatin fractionation; ChIP and TLR4-TRIF/LPS analysis for SMAR1","pmids":["35061896","34689394"],"confidence":"High","gaps":["Whether RAD51 SUMOylation is followed by STUbL-type ubiquitination not addressed here","Generality of the SMAR1 transcriptional axis beyond macrophages untested"]},{"year":2024,"claim":"The unifying biochemical logic was unresolved; defining TOPORS as a SUMO1-selective STUbL that complements RNF4, with synthetic lethality and substrate specificity for SUMOylated DNMT1-DPCs resolved RING-dependently, established its core mechanism and therapeutic vulnerability.","evidence":"Genome-scale CRISPR screens, in vitro ubiquitination, SIM mapping, p97 recruitment, double-knockout synthetic lethality; proximity proteomics and RING-mutant DNMT1-DPC resolution; xenograft HMA-synergy with DDR readout","pmids":["38649616","38760575","39198401","39198387"],"confidence":"High","gaps":["Full in vivo SUMO1-targeted substrate landscape not enumerated","Determinants of SUMO1- versus SUMO2/3-chain selectivity at structural level not fully defined"]},{"year":2025,"claim":"How SUMO-isoform selectivity directs TOPORS recruitment in cells was unclear; PML-mutant reconstitution showed TOPORS is recruited only with sufficient SUMO1 conjugation and acts in parallel with RNF4 on distinct chains to drive p97-dependent PML degradation, while a SUMOylation/TOP1 role and a USP7-TOPORS-BRCA1-A axis extend its regulation.","evidence":"PML-/- reconstitution with WT/A216T/L217F mutants and arsenic; SUMO1-TOP1 IP in stressed macrophages; quantitative proteomics after USP7 inhibition (preprint)","pmids":["40239066","40532862","bio_10.1101_2025.01.28.635372"],"confidence":"High","gaps":["USP7-TOPORS-BRCA1-A axis rests on a preprint without direct co-IP validation","Structural basis of SUMO1-selective chain recognition still incomplete"]},{"year":null,"claim":"It remains unknown how TOPORS's nuclear STUbL biochemistry mechanistically produces its retinal-ciliary disease phenotype, i.e. which substrate(s) at the photoreceptor basal body underlie RP31.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No retinal-specific TOPORS substrate identified","Link between centrosomal/basal-body localization and STUbL activity unresolved","Why haploinsufficiency manifests selectively in photoreceptors unexplained"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,1,5,8,10,16,20,22,23]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,10,16,22,23,25]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[29]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[21]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[12,11]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,4,9,29]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[3,9]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[14,18]},{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[14]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[15,19]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,22,23,26]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[20,23,24,28]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[7,15,19]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[13,22]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[9,24]}],"complexes":["PML nuclear bodies"],"partners":["TP53","RNF4","PML","RAD51","BRCA2","PSMC1","SDC1","USP7"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NS56","full_name":"E3 ubiquitin-protein ligase Topors","aliases":["RING-type E3 ubiquitin transferase Topors","SUMO1-protein E3 ligase Topors","Topoisomerase I-binding RING finger protein","Topoisomerase I-binding arginine/serine-rich protein","Tumor suppressor p53-binding protein 3","p53-binding protein 3","p53BP3"],"length_aa":1045,"mass_kda":119.2,"function":"Functions as an E3 ubiquitin-protein ligase and as an E3 SUMO1-protein ligase. Probable tumor suppressor involved in cell growth, cell proliferation and apoptosis that regulates p53/TP53 stability through ubiquitin-dependent degradation. May regulate chromatin modification through sumoylation of several chromatin modification-associated proteins. May be involved in DNA damage-induced cell death through IKBKE sumoylation","subcellular_location":"Nucleus; Nucleus, PML body","url":"https://www.uniprot.org/uniprotkb/Q9NS56/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TOPORS","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TOPORS","total_profiled":1310},"omim":[{"mim_id":"609923","title":"RETINITIS PIGMENTOSA 31; RP31","url":"https://www.omim.org/entry/609923"},{"mim_id":"609507","title":"TOPOISOMERASE I-BINDING ARGININE/SERINE-RICH PROTEIN; TOPORS","url":"https://www.omim.org/entry/609507"},{"mim_id":"268000","title":"RETINITIS PIGMENTOSA; RP","url":"https://www.omim.org/entry/268000"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TOPORS"},"hgnc":{"alias_symbol":["TP53BPL","LUN"],"prev_symbol":["RP31"]},"alphafold":{"accession":"Q9NS56","domains":[{"cath_id":"-","chopping":"114-163","consensus_level":"high","plddt":89.5592,"start":114,"end":163},{"cath_id":"-","chopping":"246-375","consensus_level":"high","plddt":88.1779,"start":246,"end":375}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NS56","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NS56-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NS56-F1-predicted_aligned_error_v6.png","plddt_mean":49.03},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TOPORS","jax_strain_url":"https://www.jax.org/strain/search?query=TOPORS"},"sequence":{"accession":"Q9NS56","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NS56.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NS56/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NS56"}},"corpus_meta":[{"pmid":"15247280","id":"PMC_15247280","title":"Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15247280","citation_count":161,"is_preprint":false},{"pmid":"16122737","id":"PMC_16122737","title":"Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.","date":"2005","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/16122737","citation_count":136,"is_preprint":false},{"pmid":"15703819","id":"PMC_15703819","title":"DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3.","date":"2005","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/15703819","citation_count":133,"is_preprint":false},{"pmid":"32697352","id":"PMC_32697352","title":"A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.","date":"2020","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32697352","citation_count":132,"is_preprint":false},{"pmid":"19473992","id":"PMC_19473992","title":"Plk1-mediated phosphorylation of Topors regulates p53 stability.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19473992","citation_count":81,"is_preprint":false},{"pmid":"12812790","id":"PMC_12812790","title":"Forkhead transcription factor Foxf2 (LUN)-deficient mice exhibit abnormal development of secondary palate.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12812790","citation_count":73,"is_preprint":false},{"pmid":"17924349","id":"PMC_17924349","title":"Mutations in TOPORS cause autosomal dominant retinitis pigmentosa with perivascular retinal pigment epithelium atrophy.","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17924349","citation_count":68,"is_preprint":false},{"pmid":"17803295","id":"PMC_17803295","title":"TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins.","date":"2007","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/17803295","citation_count":51,"is_preprint":false},{"pmid":"12083797","id":"PMC_12083797","title":"The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.","date":"2002","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12083797","citation_count":50,"is_preprint":false},{"pmid":"21159800","id":"PMC_21159800","title":"TOPORS, implicated in retinal degeneration, is a cilia-centrosomal protein.","date":"2010","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21159800","citation_count":48,"is_preprint":false},{"pmid":"14516784","id":"PMC_14516784","title":"The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation.","date":"2003","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/14516784","citation_count":45,"is_preprint":false},{"pmid":"15735665","id":"PMC_15735665","title":"topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15735665","citation_count":44,"is_preprint":false},{"pmid":"17545843","id":"PMC_17545843","title":"Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6.","date":"2007","source":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17545843","citation_count":43,"is_preprint":false},{"pmid":"18077445","id":"PMC_18077445","title":"Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18077445","citation_count":39,"is_preprint":false},{"pmid":"12546077","id":"PMC_12546077","title":"Wei Lun Visiting Professorial Lecture: Nitric oxide in the regulation of vascular function: an historical overview.","date":"2002","source":"Journal of cardiac surgery","url":"https://pubmed.ncbi.nlm.nih.gov/12546077","citation_count":39,"is_preprint":false},{"pmid":"15107820","id":"PMC_15107820","title":"The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15107820","citation_count":37,"is_preprint":false},{"pmid":"18509552","id":"PMC_18509552","title":"Mutations in the TOPORS gene cause 1% of autosomal dominant retinitis pigmentosa.","date":"2008","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/18509552","citation_count":37,"is_preprint":false},{"pmid":"17976381","id":"PMC_17976381","title":"The E3 ligase Topors induces the accumulation of polysumoylated forms of DNA topoisomerase I in vitro and in vivo.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17976381","citation_count":36,"is_preprint":false},{"pmid":"38649616","id":"PMC_38649616","title":"Concerted SUMO-targeted ubiquitin ligase activities of TOPORS and RNF4 are essential for stress management and cell proliferation.","date":"2024","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38649616","citation_count":35,"is_preprint":false},{"pmid":"35061896","id":"PMC_35061896","title":"TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/35061896","citation_count":31,"is_preprint":false},{"pmid":"38760575","id":"PMC_38760575","title":"Decitabine cytotoxicity is promoted by dCMP deaminase DCTD and mitigated by SUMO-dependent E3 ligase TOPORS.","date":"2024","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/38760575","citation_count":28,"is_preprint":false},{"pmid":"20429939","id":"PMC_20429939","title":"Deficiency of the dual ubiquitin/SUMO ligase Topors results in genetic instability and an increased rate of malignancy in mice.","date":"2010","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20429939","citation_count":24,"is_preprint":false},{"pmid":"11278651","id":"PMC_11278651","title":"Cloning and characterization of LUN, a novel ring finger protein that is highly expressed in lung and specifically binds to a palindromic sequence.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278651","citation_count":24,"is_preprint":false},{"pmid":"7644925","id":"PMC_7644925","title":"Paclitaxel plus carboplatin for advanced lung cancer: preliminary results of a Vanderbilt University phase II trial--LUN-46.","date":"1995","source":"Seminars in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/7644925","citation_count":23,"is_preprint":false},{"pmid":"9676429","id":"PMC_9676429","title":"Mouse forkhead (winged helix) gene LUN encodes a transactivator that acts in the lung.","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9676429","citation_count":21,"is_preprint":false},{"pmid":"15364129","id":"PMC_15364129","title":"Expression of LUN gene that encodes a novel RING finger protein is correlated with development and progression of non-small cell lung cancer.","date":"2004","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/15364129","citation_count":18,"is_preprint":false},{"pmid":"39198387","id":"PMC_39198387","title":"Inhibition of TOPORS ubiquitin ligase augments the efficacy of DNA hypomethylating agents through DNMT1 stabilization.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39198387","citation_count":16,"is_preprint":false},{"pmid":"19183411","id":"PMC_19183411","title":"Autosomal dominant pericentral retinal dystrophy caused by a novel missense mutation in the TOPORS gene.","date":"2009","source":"Acta ophthalmologica","url":"https://pubmed.ncbi.nlm.nih.gov/19183411","citation_count":16,"is_preprint":false},{"pmid":"14871887","id":"PMC_14871887","title":"Drosophila Topors is a RING finger-containing protein that functions as a ubiquitin-protein isopeptide ligase for the hairy basic helix-loop-helix repressor protein.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14871887","citation_count":16,"is_preprint":false},{"pmid":"32113985","id":"PMC_32113985","title":"TOPORS, a tumor suppressor protein, contributes to the maintenance of higher-order chromatin architecture.","date":"2020","source":"Biochimica et biophysica acta. Gene regulatory mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/32113985","citation_count":15,"is_preprint":false},{"pmid":"16189705","id":"PMC_16189705","title":"A new locus (RP31) for autosomal dominant retinitis pigmentosa maps to chromosome 9p.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16189705","citation_count":13,"is_preprint":false},{"pmid":"39198401","id":"PMC_39198401","title":"TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39198401","citation_count":12,"is_preprint":false},{"pmid":"26872363","id":"PMC_26872363","title":"TOPORS, a Dual E3 Ubiquitin and Sumo1 Ligase, Interacts with 26 S Protease Regulatory Subunit 4, Encoded by the PSMC1 Gene.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26872363","citation_count":11,"is_preprint":false},{"pmid":"19053840","id":"PMC_19053840","title":"Identification of phosphorylation sites of TOPORS and a role for serine 98 in the regulation of ubiquitin but not SUMO E3 ligase activity.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19053840","citation_count":11,"is_preprint":false},{"pmid":"9007120","id":"PMC_9007120","title":"Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).","date":"1996","source":"Seminars in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/9007120","citation_count":8,"is_preprint":false},{"pmid":"19821153","id":"PMC_19821153","title":"Plk1 phosphorylation of Topors is involved in its degradation.","date":"2009","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/19821153","citation_count":7,"is_preprint":false},{"pmid":"36041949","id":"PMC_36041949","title":"A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139.","date":"2022","source":"Clinical lung cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36041949","citation_count":7,"is_preprint":false},{"pmid":"22972498","id":"PMC_22972498","title":"TOPORS modulates H2AX discriminating genotoxic stresses.","date":"2012","source":"Journal of biochemical and molecular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/22972498","citation_count":6,"is_preprint":false},{"pmid":"34689394","id":"PMC_34689394","title":"RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4-TRIF pathway.","date":"2022","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34689394","citation_count":6,"is_preprint":false},{"pmid":"40239066","id":"PMC_40239066","title":"PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways.","date":"2025","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/40239066","citation_count":5,"is_preprint":false},{"pmid":"22912899","id":"PMC_22912899","title":"Inhibition of PDGF-B induction and cell growth by syndecan-1 involves the ubiquitin and SUMO-1 ligase, Topors.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22912899","citation_count":5,"is_preprint":false},{"pmid":"35579903","id":"PMC_35579903","title":"Autosomal Dominant Retinitis Pigmentosa-Associated TOPORS Protein Truncating Variants Are Exclusively Located in the Region of Amino Acid Residues 807 to 867.","date":"2022","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/35579903","citation_count":5,"is_preprint":false},{"pmid":"38065351","id":"PMC_38065351","title":"Comparative studies on the chemical composition and pharmacological effects of vinegar-processed antler glue modified from Lei Gong Pao Zhi Lun and traditional water-processed antler glue.","date":"2023","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38065351","citation_count":5,"is_preprint":false},{"pmid":"28453362","id":"PMC_28453362","title":"A novel mutation in the dominantly inherited TOPORS gene supports haploinsufficiency as the mechanism of retinitis pigmentosa.","date":"2017","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28453362","citation_count":4,"is_preprint":false},{"pmid":"19561551","id":"PMC_19561551","title":"Impact of the ASCO 2007 presentation of HOG Lun 01-24/USO-023 on the prescribing plans of American medical oncologists for patients with stage IIIB non-small cell lung cancer.","date":"2009","source":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19561551","citation_count":4,"is_preprint":false},{"pmid":"37227088","id":"PMC_37227088","title":"TOPORS as a novel causal gene for Joubert syndrome.","date":"2023","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/37227088","citation_count":3,"is_preprint":false},{"pmid":"35254173","id":"PMC_35254173","title":"Mutations of TOPORS identified in families with retinitis pigmentosa.","date":"2022","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35254173","citation_count":3,"is_preprint":false},{"pmid":"38592336","id":"PMC_38592336","title":"Autosomal Dominant Retinitis Pigmentosa Secondary to TOPORS Mutations: A Report of a Novel Mutation and Clinical Findings.","date":"2024","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38592336","citation_count":3,"is_preprint":false},{"pmid":"39824659","id":"PMC_39824659","title":"Association of Immune-Related Adverse Events With Efficacy in Consolidation Nivolumab Plus Ipilimumab or Nivolumab Alone After Chemoradiation in Patients With Unresectable Stage III Nonsmall Cell Lung Cancer: An Exploratory Analysis From the Big 10 Cancer Research Consortium Study BTCRC LUN 16-081.","date":"2024","source":"Clinical lung cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39824659","citation_count":3,"is_preprint":false},{"pmid":"39670007","id":"PMC_39670007","title":"Phase Ib/II study of imprime PGG and pembrolizumab in patients with previously treated advanced non-small cell lung cancer (NSCLC): BTCRC LUN 15-017.","date":"2024","source":"Translational lung cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/39670007","citation_count":2,"is_preprint":false},{"pmid":"25503432","id":"PMC_25503432","title":"Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130.","date":"2017","source":"American journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25503432","citation_count":2,"is_preprint":false},{"pmid":"40532862","id":"PMC_40532862","title":"Modulation of SUMO1-TOP1 DNA damage repair by TOPORS following ovalbumin-induced oxidative stress in macrophages.","date":"2025","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/40532862","citation_count":1,"is_preprint":false},{"pmid":"39697236","id":"PMC_39697236","title":"miR-198 targets TOPORS: implications for oral squamous cell carcinoma pathogenesis.","date":"2024","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/39697236","citation_count":1,"is_preprint":false},{"pmid":"41892699","id":"PMC_41892699","title":"Study on the Role and Mechanism of TOPORS in Regulating Aortic Dissection by Mediating SUMOylation.","date":"2026","source":"Journal of cardiovascular development and disease","url":"https://pubmed.ncbi.nlm.nih.gov/41892699","citation_count":0,"is_preprint":false},{"pmid":"31296957","id":"PMC_31296957","title":"Correction: The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31296957","citation_count":0,"is_preprint":false},{"pmid":"40358237","id":"PMC_40358237","title":"Trigeminal Neuralgia in a 12-Month-Old Boy With Dandy-Walker Malformation and Homozygous Pathogenic TOPORS Variant.","date":"2025","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/40358237","citation_count":0,"is_preprint":false},{"pmid":"20862948","id":"PMC_20862948","title":"[Characteristics of acupuncture in Shanghan Lun (Treatise on Febrile Diseases)].","date":"2010","source":"Zhongguo zhen jiu = Chinese acupuncture & moxibustion","url":"https://pubmed.ncbi.nlm.nih.gov/20862948","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.01.28.635372","title":"USP7 inhibition perturbs proteostasis and tumorigenesis in triple negative breast cancer","date":"2025-02-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.28.635372","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.17.634645","title":"Structure-based analysis unveils co-origin of LPOR and nitrogenase-like proteins","date":"2025-02-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.17.634645","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":29044,"output_tokens":7545,"usd":0.100154,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16976,"output_tokens":6443,"usd":0.122978,"stage2_stop_reason":"end_turn"},"total_usd":0.223132,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"TOPORS functions as a RING domain-dependent E3 ubiquitin ligase in vitro, utilizing E2 enzymes UbcH5a, UbcH5c, and UbcH6 (but not UbcH7, CDC34, or UbcH2b), and ubiquitinates p53 both in vitro and in cells; a conserved tryptophan in the RING domain is required for ubiquitination activity; overexpression leads to proteasome-dependent decrease in p53 protein levels.\",\n      \"method\": \"In vitro ubiquitination assay, RING domain mutagenesis, cellular overexpression with proteasome inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis, multiple E2 specificity tested, replicated in cellular context\",\n      \"pmids\": [\"15247280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TOPORS acts as a SUMO-1 E3 ligase for p53, enhancing SUMO-1 conjugation to p53 both in vivo and in a reconstituted in vitro system; this SUMO-1 E3 ligase activity does not require the RING finger motif; in HeLa cells, Topors-induced p53 sumoylation was accompanied by increased endogenous p53 protein levels.\",\n      \"method\": \"Reconstituted in vitro SUMO-1 conjugation assay, cellular co-transfection, RING finger deletion mutants\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution plus cellular validation, RING-independence established by mutagenesis\",\n      \"pmids\": [\"16122737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DJ-1 binds TOPORS/p53BP3 in vitro and in vivo; TOPORS mediates sumoylation of both p53 and DJ-1 in cells; TOPORS-mediated sumoylation of p53 abrogates p53 transcriptional activity in a dose-dependent manner; DJ-1 restores repressed p53 transcriptional activity by releasing the sumoylated form of p53.\",\n      \"method\": \"Co-IP, in vitro binding assay, co-localization, transcriptional reporter assay, cellular sumoylation assay\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal binding confirmed in vitro and in vivo, functional consequence on p53 transcription measured; single lab\",\n      \"pmids\": [\"15703819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Topors localizes to promyelocytic leukemia (PML) nuclear bodies in a PML-dependent manner; the basic C-terminal region (not the RING domain) is required for punctate nuclear localization; topors dynamically relocalizes from nuclear bodies to the nucleoplasm upon treatment with transcription inhibitor DRB or the topoisomerase I-targeting drug camptothecin.\",\n      \"method\": \"GFP fusion live imaging, fractionation, isogenic PML+/+ vs PML-/- MEFs, domain deletion analysis, drug treatment\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization with functional domain mapping, isogenic cell comparison, multiple treatments\",\n      \"pmids\": [\"12083797\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TOPORS is itself a SUMO-1 modification target; it interacts with SUMO-1 and the SUMO-1 conjugating enzyme UBC9 in yeast two-hybrid; multiple SUMO-1 modified forms of Topors are detected after co-transfection; lysine 560 within the central domain (residues 437–574) is a SUMO-1 acceptor site; sumoylation-deficient mutants show that sumoylation is not required for localization to nuclear speckles.\",\n      \"method\": \"Yeast two-hybrid, co-transfection and immunoblot, YFP-SUMO-1 colocalization, site-directed mutagenesis\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-directed mutagenesis identifying K560, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"14516784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Drosophila Topors (dTopors) functions as an E3 ubiquitin-protein isopeptide ligase in vitro and mediates polyubiquitination and degradation of the Hairy transcriptional repressor; dTopors binds specifically to the basic region of Hairy but does not affect Hairy's DNA binding; reducing dtopors gene dose genetically antagonizes Hairy-mediated transcriptional repression.\",\n      \"method\": \"In vitro ubiquitination assay with recombinant dTopors, genetic dose reduction (epistasis), co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution plus genetic epistasis in Drosophila ortholog, multiple orthogonal methods\",\n      \"pmids\": [\"14871887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Mouse topors associates with and stabilizes p53, enhances p53-dependent transcriptional activities (p21Waf1, MDM2, Bax promoters), elevates endogenous p21Waf1 mRNA, and overexpression suppresses cell growth by cell cycle arrest and/or apoptosis; topors expression is induced by genotoxic agents cisplatin and camptothecin.\",\n      \"method\": \"Co-IP, transcriptional reporter assays, RT-PCR, cell growth/apoptosis assays, overexpression\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional readouts (transcription, growth, apoptosis) in single lab; co-IP validates physical association\",\n      \"pmids\": [\"15735665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins; proteomic screen identified candidate substrates involved in chromatin modification/transcriptional regulation; mammalian Sin3A was confirmed as a sumoylation substrate for TOPORS by transfection studies.\",\n      \"method\": \"Proteomic screen, transfection-based sumoylation assay\",\n      \"journal\": \"Journal of proteome research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — substrate confirmed by cellular assay, no in vitro reconstitution for Sin3A; single lab\",\n      \"pmids\": [\"17803295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TOPORS enhances formation of high-molecular-weight SUMO-1 conjugates (poly-SUMO-1 chains) on DNA topoisomerase I (TOP1) in a reconstituted in vitro system and in human osteosarcoma cells; TOP1 point mutants suggest chains form on a limited number of SUMO-1 acceptor sites.\",\n      \"method\": \"Reconstituted in vitro SUMO-1 conjugation assay, cellular overexpression, TOP1 point mutant analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis of substrate, replicated in cells; single lab\",\n      \"pmids\": [\"17976381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TOPORS mutations (insertion and deletion causing haploinsufficiency) cause autosomal dominant retinitis pigmentosa (RP31); TOPORS localizes in the nucleus in speckled loci associated with PML bodies; lack of mutant protein in patients suggests haploinsufficiency as disease mechanism.\",\n      \"method\": \"Positional cloning, mutation identification by sequencing, immunolocalization\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — positional cloning with functional localization; disease mechanism established by genetics and protein expression analysis\",\n      \"pmids\": [\"17924349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TOPORS ubiquitinates the prostate tumor suppressor NKX3.1 in vitro and in vivo; overexpression of TOPORS leads to NKX3.1 proteasomal degradation in prostate cancer cells; siRNA knockdown of TOPORS increases steady-state NKX3.1 levels and prolongs its half-life.\",\n      \"method\": \"In vitro ubiquitination assay, cellular overexpression, siRNA knockdown, cycloheximide chase\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution plus loss-of-function and gain-of-function cellular studies with half-life measurement\",\n      \"pmids\": [\"18077445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Phosphorylation of serine 98 (adjacent to the RING domain) regulates TOPORS ubiquitin ligase activity: S98D (phosphomimetic) increases ubiquitin ligase activity and binding to E2 enzyme UbcH5a both in vitro and in cells; this phosphorylation does not affect SUMO ligase activity or punctate nuclear localization. Multiple phosphorylated regions were identified by mass spectrometry.\",\n      \"method\": \"Mass spectrometry, site-directed mutagenesis (S98A, S98D), in vitro ubiquitination assay, co-IP with E2\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with in vitro assay and cellular validation; clear separation of ubiquitin vs SUMO activities\",\n      \"pmids\": [\"19053840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Plk1 phosphorylates Topors on Ser718 in vivo; expression of Plk1-unphosphorylatable Topors (S718A) leads to dramatic p53 accumulation through inhibition of p53 degradation; Plk1-mediated phosphorylation of Topors inhibits Topors-mediated sumoylation of p53 while enhancing p53 ubiquitination, leading to p53 degradation.\",\n      \"method\": \"In vivo phosphorylation assay, site-directed mutagenesis (S718A), p53 stability assay, ubiquitination and sumoylation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — phosphorylation site identified in vivo with phospho-deficient mutant, mechanistic dissection of opposing E3 activities\",\n      \"pmids\": [\"19473992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Plk1-associated phosphorylation of Topors at S718 is essential for nocodazole-induced degradation of Topors; Topors depletion delays mitotic entry and affects mitotic progression, implicating Topors in normal mitotic progression.\",\n      \"method\": \"Spindle checkpoint activation (nocodazole), siRNA knockdown, phosphorylation analysis\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — loss-of-function with defined mitotic phenotype, single lab, single method confirmation\",\n      \"pmids\": [\"19821153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TOPORS localizes to the basal bodies of the connecting cilium in photoreceptors and to centrosomes in cultured cells; morpholino-mediated silencing of topors in zebrafish results in defective retinal development and failure to form outer segments, phenotypes rescued by mRNA encoding human TOPORS.\",\n      \"method\": \"Immunolocalization in retinal sections, morpholino knockdown in zebrafish, mRNA rescue experiment\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization tied to functional consequence, loss-of-function with rescue in zebrafish model\",\n      \"pmids\": [\"21159800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Topors-deficient mouse embryonic fibroblasts exhibit increased malignant transformation associated with aneuploidy and defective chromosomal segregation; Topors-deficient cells show mislocalization of HP1alpha and increased transcription from pericentric major satellite DNA, indicating altered pericentric heterochromatin; these cells are resistant to anti-proliferative effects of the HDAC inhibitor trichostatin A.\",\n      \"method\": \"Topors knockout mouse, MEF transformation assay, FISH for aneuploidy, HP1alpha immunolocalization, RT-PCR of satellite DNA, HDAC inhibitor treatment\",\n      \"journal\": \"BMC molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse model with multiple orthogonal mechanistic readouts (chromosomal segregation, heterochromatin, HDAC sensitivity)\",\n      \"pmids\": [\"20429939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TOPORS interacts with H2AX and functions as an E3 ubiquitin ligase for H2AX in vitro; TOPORS overexpression decreases H2AX protein stability; TOPORS dissociates from H2AX under oxidative stress (hydrogen peroxide, ionizing radiation) but not under replication-stress-inducing damage.\",\n      \"method\": \"Co-IP from mammalian cell extracts, in vitro ubiquitination assay, overexpression stability assay, stress-dependent dissociation analysis\",\n      \"journal\": \"Journal of biochemical and molecular toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vitro ubiquitination with cellular co-IP and functional consequence; single lab, limited methods\",\n      \"pmids\": [\"22972498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Syndecan-1 cytoplasmic domain (S1CD) interacts with Topors via a specific 18-amino acid sequence of Topors identified by deletion mutagenesis; Topors and Sdc-1 co-localize near the cell periphery; siRNA knockdown of Topors demonstrates Topors is required for the inhibitory effect of Sdc-1 on cell growth and PDGF-B induction in arterial smooth muscle cells.\",\n      \"method\": \"Yeast two-hybrid, ligand blotting, co-precipitation, deletion mutagenesis, immunohistochemistry, siRNA knockdown\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — interaction domain mapped by mutagenesis, functional consequence confirmed by siRNA; single lab\",\n      \"pmids\": [\"22912899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TOPORS interacts with the 26S protease regulatory subunit 4 (P26s4/PSMC1), an ATPase component of the proteasome; interaction validated by yeast two-hybrid, co-immunoprecipitation from mammalian cells, and immunofluorescent co-localization; TOPORS and P26s4 co-localize at the centrosome in cultured hTERT-RPE1 and 661W cells.\",\n      \"method\": \"Yeast two-hybrid screen of human retinal cDNA library, co-IP from mammalian cells, immunofluorescence co-localization\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — interaction validated by reciprocal co-IP and two cell line co-localization; single lab\",\n      \"pmids\": [\"26872363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TOPORS knockdown in mouse hepatocytes increases chromatin interactions between A and B compartments, reduces compartmentalization strength, weakens TAD boundaries at A/B borders, decreases chromatin-lamina interactions (LAD coverage from 53.31% to 46.52%), and alters chromatin accessibility predominantly at intergenic regions including enhancers; these changes are associated with PML nuclear bodies and PML-associated domains.\",\n      \"method\": \"Hi-C, ATAC-seq, ChIP-seq, RNA-seq after Topors knockdown in mouse hepatocytes\",\n      \"journal\": \"Biochimica et biophysica acta. Gene regulatory mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genome-wide orthogonal methods; single lab, loss-of-function with defined chromatin structural phenotype\",\n      \"pmids\": [\"32113985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TOPORS mediates SUMOylation of RAD51 at lysine residues K57 and K70 in response to DNA damage; this SUMOylation is facilitated by ATM-induced phosphorylation of TOPORS at threonine 515; SUMOylation-deficient RAD51 mutants exhibit reduced chromatin loading and HR repair efficiency, and reduced association with BRCA2.\",\n      \"method\": \"In vivo SUMOylation assay, site-directed mutagenesis of RAD51 (K57R, K70R), phosphorylation analysis of TOPORS T515, HR repair assay, co-IP with BRCA2, chromatin fractionation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — specific SUMOylation sites mapped by mutagenesis, upstream kinase identified, functional consequence in HR repair with mechanistic explanation (BRCA2 interaction)\",\n      \"pmids\": [\"35061896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TOPORS binds the SMAR1 promoter (confirmed by ChIP) and its occupancy increases upon LPS treatment; TOPORS is induced via the TLR4-TRIF pathway by LPS; TOPORS-mediated transcriptional upregulation of SMAR1 subsequently represses STAT3 and shifts tumor-associated macrophage polarization toward M1 phenotype.\",\n      \"method\": \"ChIP analysis, siRNA knockdown, LPS treatment, macrophage polarization assay\",\n      \"journal\": \"Molecular oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms direct promoter binding; pathway placement by genetic knockdown; single lab\",\n      \"pmids\": [\"34689394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TOPORS functions as a SUMO-targeted ubiquitin ligase (STUbL), combining RING domain-mediated ubiquitin ligase activity with poly-SUMO binding via SUMO-interacting motifs; TOPORS is SUMO1-selective and complements RNF4 (which is SUMO2/3-selective) in generating complex ubiquitin landscapes on SUMOylated targets including DNA-protein crosslinks (DPCs) and PML, stimulating p97/VCP recruitment and proteasomal degradation; combined loss of TOPORS and RNF4 is synthetic lethal in unstressed cells due to defective clearance of SUMOylated proteins from chromatin, leading to cell cycle arrest and apoptosis.\",\n      \"method\": \"Genome-scale CRISPR screens, in vitro ubiquitination assay, SUMO-interaction motif mapping, p97 recruitment assay, synthetic lethality double-knockout, cell cycle analysis\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genome-scale screens combined with in vitro reconstitution, domain mapping, synthetic lethality, and mechanistic pathway placement; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"38649616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TOPORS is recruited to SUMOylated DNMT1-DNA protein crosslinks (DPCs) and promotes their ubiquitin-dependent degradation; TOPORS knockout stabilizes SUMOylated DNMT1 following treatment with DNA hypomethylating agents (5-aza-dC); the TOPORS RING finger domain is responsible for this ubiquitination-mediated DPC resolution.\",\n      \"method\": \"CRISPR/Cas9 screens, proximity proteomics of DNMT1-DPC, TOPORS knockout/knockdown, SUMOylated DNMT1 immunoblot, RING domain mutant analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-scale screen plus proximity proteomics plus genetic knockout with domain mapping; two independent groups confirmed mechanistically overlapping findings\",\n      \"pmids\": [\"38760575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TOPORS knockout predisposes leukemic blasts to impaired DNA damage response (DDR) and accumulation of SUMOylated DNMT1 when treated with HMAs; depletion of TOPORS synergizes with HMAs to reduce leukemic burden in xenograft models; combination does not impair healthy hematopoiesis.\",\n      \"method\": \"Genome-wide CRISPR-Cas9 screen, xenograft mouse model, SUMOylated DNMT1 immunoblot, DDR assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide screen with in vivo xenograft validation and mechanistic DDR readout; independent replication of TOPORS-DPC mechanism across multiple labs\",\n      \"pmids\": [\"39198401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TOPORS knockout stabilizes DNMT1 by preventing its ubiquitination following HMA treatment, resulting in accumulation of unresolved SUMOylated DNMT1; the TOPORS RING finger domain mediates ubiquitination of SUMOylated DNMT1, promoting resolution of DNA-DNMT1 crosslinks.\",\n      \"method\": \"CRISPR-Cas9 knockout, DNMT1 stability assay, ubiquitination assay, RING finger domain analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain-level mechanism established, independent replication of DPC/DNMT1 substrate across three concurrent publications\",\n      \"pmids\": [\"39198387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TOPORS is a SUMO1-selective STUbL that is recruited to PML only when sufficient SUMO1 conjugation occurs (not SUMO2/3 alone); arsenic-resistant PML mutant A216T fails to recruit TOPORS because arsenic does not trigger its SUMOylation; arsenic-resistant PML mutant L217F acquires SUMO2/3 but not SUMO1 conjugation sufficient to recruit TOPORS; thus TOPORS and RNF4 act in parallel on distinct SUMO chains to generate the polyubiquitin signal for p97 binding and PML degradation.\",\n      \"method\": \"PML-/- cell reconstitution with YFP-PML fusions (WT, A216T, L217F), arsenic treatment, SUMO-1 and SUMO2/3 conjugation assays, TOPORS and RNF4 recruitment assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — isogenic cell reconstitution with patient-derived mutants, SUMO isoform selectivity mechanistically dissected, multiple orthogonal methods\",\n      \"pmids\": [\"40239066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TOPORS is identified as a substrate of the deubiquitinase USP7; USP7 inhibition leads to reduced TOPORS protein levels; TOPORS interacts with the BRCA1-A DNA damage repair complex, suggesting a USP7-TOPORS-BRCA1-A axis.\",\n      \"method\": \"Quantitative proteomics after USP7 inhibition, protein interaction network analysis (BRCA1-A complex co-identification)\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, proteomics-based substrate inference; BRCA1-A interaction not directly validated by co-IP in this abstract\",\n      \"pmids\": [\"bio_10.1101_2025.01.28.635372\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TOPORS regulates SUMO1 modification of TOP1 in macrophages exposed to ovalbumin-induced oxidative stress; knockdown of TOPORS reduces SUMO1-TOP1 levels and increases unrepaired DNA damage (γH2AX), indicating TOPORS-mediated TOP1 sumoylation contributes to DNA damage repair in this context.\",\n      \"method\": \"Immunoprecipitation of SUMO1-TOP1, siRNA knockdown of TOPORS, γH2AX immunoblot in OVA-stimulated macrophages\",\n      \"journal\": \"Toxicology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — co-IP validated SUMOylation with functional readout (γH2AX); single lab, single context\",\n      \"pmids\": [\"40532862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"LUN/TOPORS (RING finger protein) localizes to the nucleus and exhibits Zn2+-dependent DNA binding activity; the region from amino acids 51–374 is responsible for DNA binding; a palindromic binding consensus sequence (5'-TCCCAGCACTTTGGGA-3') was identified for LUN/TOPORS binding.\",\n      \"method\": \"Nuclear localization by immunofluorescence, DNA binding assay (Zn2+-dependence), deletion mapping, binding consensus identification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct DNA binding demonstrated with domain mapping and consensus sequence identification; single lab\",\n      \"pmids\": [\"11278651\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TOPORS is a dual E3 ligase—bearing both ubiquitin (RING domain-dependent, with E2 selectivity for UbcH5a/c and UbcH6) and SUMO-1 (RING-independent) activities—that acts as a SUMO1-selective SUMO-targeted ubiquitin ligase (STUbL) complementing RNF4 to generate complex ubiquitin landscapes on poly-SUMOylated substrates including p53, NKX3.1, H2AX, DNA topoisomerase I, RAD51, Sin3A, and DNMT1-DNA protein crosslinks, thereby regulating proteasomal degradation via p97/VCP recruitment, homologous recombination repair, pericentric heterochromatin integrity, and 3D chromatin architecture; its activities are regulated by phosphorylation (Plk1 on S718 and ATM on T515), it localizes to PML nuclear bodies (C-terminal basic region required) and to centrosomes/basal bodies of photoreceptor cilia, and haploinsufficiency or specific C-terminal truncating mutations in the 807–867 region cause autosomal dominant retinitis pigmentosa.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TOPORS is a dual-function nuclear E3 ligase that conjugates both ubiquitin and SUMO-1 to substrates, thereby coupling SUMO signaling to proteasomal turnover and chromatin regulation [#0, #1]. Its ubiquitin ligase activity depends on an intact RING domain and a conserved tryptophan, and operates through the E2 enzymes UbcH5a, UbcH5c, and UbcH6 [#0], whereas its SUMO-1 ligase activity is RING-independent [#1]. This bifunctionality is integrated at the level of individual targets: on p53, TOPORS can both stabilize the protein through SUMOylation and drive its proteasomal degradation through ubiquitination, with the balance set by phosphorylation [#0, #1, #12]. The mature mechanistic model casts TOPORS as a SUMO1-selective SUMO-targeted ubiquitin ligase (STUbL) that recognizes poly-SUMO1 chains via SUMO-interacting motifs and complements the SUMO2/3-selective RNF4, the two acting in parallel on distinct SUMO chains to build the polyubiquitin signal that recruits p97/VCP and triggers degradation; combined loss of TOPORS and RNF4 is synthetic lethal due to failed clearance of SUMOylated chromatin proteins [#22, #26]. Through this activity TOPORS ubiquitinates SUMOylated DNA-protein crosslinks, most notably DNMT1-DPCs formed after hypomethylating-agent treatment, promoting their RING-dependent resolution—a dependency exploited therapeutically in leukemia [#23, #24, #25]. TOPORS also SUMOylates RAD51 at K57 and K70 downstream of ATM-mediated phosphorylation of TOPORS T515, promoting RAD51 chromatin loading, BRCA2 association, and homologous recombination repair [#20]. Additional substrates include NKX3.1, which it targets for proteasomal degradation [#10], topoisomerase I and Sin3A, which it poly-SUMOylates [#7, #8]. TOPORS localizes to PML nuclear bodies via its basic C-terminal region in a PML-dependent manner [#3] and to centrosomes and photoreceptor connecting-cilium basal bodies [#14, #18], and its activities are temporally controlled by Plk1 phosphorylation at S718 [#12]. Loss-of-function studies link TOPORS to pericentric heterochromatin integrity, chromosome segregation, and 3D chromatin compartmentalization [#15, #19]. Haploinsufficiency and truncating TOPORS mutations cause autosomal dominant retinitis pigmentosa (RP31) [#9].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Before any enzymatic role was known, the question was whether TOPORS had intrinsic nucleic-acid activity; demonstrating Zn2+-dependent sequence-specific DNA binding established it as a nuclear factor capable of chromatin association.\",\n      \"evidence\": \"Immunofluorescence, Zn2+-dependent DNA-binding assay, deletion mapping and consensus identification for LUN/TOPORS\",\n      \"pmids\": [\"11278651\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No demonstrated transcriptional output from this DNA-binding consensus in vivo\", \"Relationship between DNA binding and later-defined ligase activities unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"The subnuclear address of TOPORS was unknown; localization to PML nuclear bodies dependent on PML and on a basic C-terminal region, with drug-induced relocalization, placed TOPORS at the SUMO/PML hub and mapped the targeting determinant.\",\n      \"evidence\": \"GFP live imaging, PML+/+ vs PML-/- MEFs, domain deletion, DRB and camptothecin treatment\",\n      \"pmids\": [\"12083797\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of PML-body residence not addressed at this stage\", \"Mechanism of camptothecin-induced relocalization unexplained\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Whether TOPORS itself is SUMO-regulated was untested; identifying K560 as a SUMO-1 acceptor and UBC9/SUMO-1 interactions showed TOPORS is a SUMO substrate, foreshadowing its embedding in the SUMO machinery.\",\n      \"evidence\": \"Yeast two-hybrid, co-transfection immunoblot, YFP-SUMO-1 colocalization, K560 mutagenesis\",\n      \"pmids\": [\"14516784\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of TOPORS auto-SUMOylation undefined (not required for localization)\", \"Did not establish TOPORS as a SUMO ligase itself\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The catalytic identity of TOPORS was open; reconstitution showed RING-dependent ubiquitin ligase activity with defined E2 selectivity and p53 as a degradation substrate, defining its first enzymatic function.\",\n      \"evidence\": \"In vitro ubiquitination with E2 panel, RING tryptophan mutagenesis, cellular overexpression with proteasome inhibitor; Drosophila ortholog ubiquitinating Hairy with genetic epistasis\",\n      \"pmids\": [\"15247280\", \"14871887\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo physiological substrate repertoire not yet defined\", \"Did not reconcile p53 degradation with later p53-stabilizing observations\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"It was unclear whether TOPORS had a second catalytic activity; demonstrating RING-independent SUMO-1 ligase activity toward p53 (and DJ-1), with opposing effects on p53 stability and transcription, established TOPORS as a dual ubiquitin/SUMO ligase.\",\n      \"evidence\": \"Reconstituted in vitro SUMO-1 assays, RING-deletion mutants, co-IP, transcriptional reporters, mouse Topors p53 stabilization studies\",\n      \"pmids\": [\"16122737\", \"15703819\", \"15735665\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a single enzyme reconciles ubiquitination-driven degradation and SUMOylation-driven stabilization of p53 not yet resolved\", \"Physiological switch between the two activities unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The substrate breadth and chromatin role were unclear; identifying Sin3A and demonstrating poly-SUMO-1 chain formation on TOP1 broadened the SUMO-ligase function toward chromatin and topoisomerase regulation.\",\n      \"evidence\": \"Proteomic substrate screen, transfection sumoylation of Sin3A, reconstituted poly-SUMO-1 chain assay on TOP1 with mutant mapping\",\n      \"pmids\": [\"17803295\", \"17976381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No in vitro reconstitution for Sin3A SUMOylation\", \"Downstream fate of poly-SUMO-1 chains not yet linked to ubiquitin/degradation\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Whether TOPORS dysfunction causes human disease was unknown; positional cloning tied haploinsufficiency-causing mutations to autosomal dominant retinitis pigmentosa (RP31), establishing a Mendelian phenotype.\",\n      \"evidence\": \"Positional cloning, mutation sequencing, immunolocalization to PML-associated speckles; NKX3.1 ubiquitination/degradation in parallel cancer study\",\n      \"pmids\": [\"17924349\", \"18077445\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of retinal-specific vulnerability not explained by haploinsufficiency alone\", \"Connection between p53/NKX3.1 ligase activity and retinal degeneration unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"How the two ligase activities are independently regulated was unknown; phosphorylation at S98 selectively stimulating ubiquitin ligase activity and E2 binding without affecting SUMO activity showed the activities are separable post-translational switches.\",\n      \"evidence\": \"Mass spectrometry, S98A/S98D mutants, in vitro ubiquitination, co-IP with UbcH5a\",\n      \"pmids\": [\"19053840\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for S98 phosphorylation not identified\", \"Physiological trigger for this modification unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The cell-cycle control of TOPORS activity was undefined; Plk1 phosphorylation at S718 was shown to flip TOPORS from p53-SUMOylation toward p53-ubiquitination/degradation and to govern TOPORS turnover and mitotic progression.\",\n      \"evidence\": \"In vivo phosphorylation, S718A mutant, p53 stability/ubiquitination/sumoylation assays; nocodazole and siRNA mitotic phenotyping\",\n      \"pmids\": [\"19473992\", \"19821153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which one phosphorylation toggles between two enzymatic outputs not structurally defined\", \"Mitotic substrates other than p53 not identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The cellular and organismal consequences of TOPORS loss were unclear; knockout MEFs revealed roles in chromosome segregation and pericentric heterochromatin, while zebrafish silencing tied TOPORS to ciliary/photoreceptor outer-segment formation with human-mRNA rescue.\",\n      \"evidence\": \"Topors knockout mouse MEFs, FISH aneuploidy, HP1alpha localization, satellite RT-PCR, HDAC inhibitor sensitivity; zebrafish morpholino with rescue and basal-body localization\",\n      \"pmids\": [\"20429939\", \"21159800\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular substrate underlying heterochromatin and segregation defects not identified\", \"Mechanistic link between nuclear ligase activity and ciliary basal-body function unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Additional substrates and cytoplasmic partners were sought; TOPORS was shown to ubiquitinate H2AX (with stress-dependent dissociation) and to bind the syndecan-1 cytoplasmic domain required for growth inhibition, extending its reach to DNA-damage histones and membrane signaling.\",\n      \"evidence\": \"Co-IP, in vitro H2AX ubiquitination, stability assays, oxidative-stress dissociation; yeast two-hybrid, deletion mapping and siRNA for syndecan-1\",\n      \"pmids\": [\"22972498\", \"22912899\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"H2AX work limited to single lab without reciprocal stress validation\", \"Syndecan-1/TOPORS axis mechanism downstream of binding not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"How TOPORS connects to the degradation machinery and to its disease-relevant localization was unclear; interaction with the proteasomal ATPase PSMC1 and co-localization at the centrosome linked TOPORS physically to the proteasome at a structure relevant to RP.\",\n      \"evidence\": \"Retinal cDNA yeast two-hybrid, reciprocal co-IP, immunofluorescence co-localization in RPE1 and 661W cells\",\n      \"pmids\": [\"26872363\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of TOPORS-PSMC1 interaction at the centrosome untested\", \"Single lab; not connected to specific substrate degradation\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Whether TOPORS shapes genome architecture was unknown; knockdown altering A/B compartmentalization, TAD boundaries, lamina interactions and accessibility tied TOPORS to 3D chromatin organization linked to PML domains.\",\n      \"evidence\": \"Hi-C, ATAC-seq, ChIP-seq, RNA-seq after Topors knockdown in mouse hepatocytes\",\n      \"pmids\": [\"32113985\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular mediator of architectural changes not identified\", \"Causality versus secondary effect of PML-body disruption unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Whether TOPORS participates in HR repair was open; mapping ATM-dependent T515 phosphorylation and TOPORS-mediated RAD51 SUMOylation at K57/K70 promoting chromatin loading and BRCA2 association placed TOPORS in the damage-induced HR pathway, alongside an immune transcriptional role at the SMAR1 promoter.\",\n      \"evidence\": \"In vivo SUMOylation, RAD51 and TOPORS site mutants, HR assay, BRCA2 co-IP, chromatin fractionation; ChIP and TLR4-TRIF/LPS analysis for SMAR1\",\n      \"pmids\": [\"35061896\", \"34689394\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RAD51 SUMOylation is followed by STUbL-type ubiquitination not addressed here\", \"Generality of the SMAR1 transcriptional axis beyond macrophages untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"The unifying biochemical logic was unresolved; defining TOPORS as a SUMO1-selective STUbL that complements RNF4, with synthetic lethality and substrate specificity for SUMOylated DNMT1-DPCs resolved RING-dependently, established its core mechanism and therapeutic vulnerability.\",\n      \"evidence\": \"Genome-scale CRISPR screens, in vitro ubiquitination, SIM mapping, p97 recruitment, double-knockout synthetic lethality; proximity proteomics and RING-mutant DNMT1-DPC resolution; xenograft HMA-synergy with DDR readout\",\n      \"pmids\": [\"38649616\", \"38760575\", \"39198401\", \"39198387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full in vivo SUMO1-targeted substrate landscape not enumerated\", \"Determinants of SUMO1- versus SUMO2/3-chain selectivity at structural level not fully defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"How SUMO-isoform selectivity directs TOPORS recruitment in cells was unclear; PML-mutant reconstitution showed TOPORS is recruited only with sufficient SUMO1 conjugation and acts in parallel with RNF4 on distinct chains to drive p97-dependent PML degradation, while a SUMOylation/TOP1 role and a USP7-TOPORS-BRCA1-A axis extend its regulation.\",\n      \"evidence\": \"PML-/- reconstitution with WT/A216T/L217F mutants and arsenic; SUMO1-TOP1 IP in stressed macrophages; quantitative proteomics after USP7 inhibition (preprint)\",\n      \"pmids\": [\"40239066\", \"40532862\", \"bio_10.1101_2025.01.28.635372\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"USP7-TOPORS-BRCA1-A axis rests on a preprint without direct co-IP validation\", \"Structural basis of SUMO1-selective chain recognition still incomplete\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how TOPORS's nuclear STUbL biochemistry mechanistically produces its retinal-ciliary disease phenotype, i.e. which substrate(s) at the photoreceptor basal body underlie RP31.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No retinal-specific TOPORS substrate identified\", \"Link between centrosomal/basal-body localization and STUbL activity unresolved\", \"Why haploinsufficiency manifests selectively in photoreceptors unexplained\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 1, 5, 8, 10, 16, 20, 22, 23]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 10, 16, 22, 23, 25]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [29]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [12, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 4, 9, 29]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [3, 9]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [14, 18]},\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [14]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [15, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 22, 23, 26]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [20, 23, 24, 28]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [7, 15, 19]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [13, 22]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [9, 24]}\n    ],\n    \"complexes\": [\"PML nuclear bodies\"],\n    \"partners\": [\"TP53\", \"RNF4\", \"PML\", \"RAD51\", \"BRCA2\", \"PSMC1\", \"SDC1\", \"USP7\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":10,"faith_total":10,"faith_pct":100.0}}